	US 12,275,719 B2
	Small molecule inhibitors of galectin-3
Chunjian Liu, Pennington, NJ (US); David S. Yoon, Ambler, PA (US); Wei Wang, Princeton, NJ (US); Jianxin Feng, Bensalem, PA (US); Bruce A. Ellsworth, Princeton, NJ (US); and Alicia Regueiro-Ren, New Hope, PA (US)
Assigned to Bristol-Myers Squibb Company, Princeton, NJ (US)
Appl. No. 17/439,845
Filed by BRISTOL-MYERS SQUIBB COMPANY, Princeton, NJ (US)
PCT Filed Mar. 25, 2020, PCT No. PCT/US2020/024548 § 371(c)(1), (2) Date Sep. 16, 2021, PCT Pub. No. WO2020/198266, PCT Pub. Date Oct. 1, 2020.
Claims priority of provisional application 62/823,684, filed on Mar. 26, 2019.
Prior Publication US 2022/0185800 A1, Jun. 16, 2022
Int. Cl. C07H 17/02 (2006.01); C07D 405/14 (2006.01); C07D 417/14 (2006.01); C07H 19/056 (2006.01)

CPC C07D 405/14 (2013.01) [C07D 417/14 (2013.01); C07H 17/02 (2013.01); C07H 19/056 (2013.01)]

4 Claims

1. A compound selected from:

or a pharmaceutically acceptable salt thereof.